ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39596162

A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability.

Frenț OD and 7 others. Int J Mol Sci, 2024. Cited by 73 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability. Papers, record 39596162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596162

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Systematic Review, Journal Article
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
18.52, provisional
iCite
Revised in PubMed
2025-07-11
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Frenț ODOlimpia-Danielahttps://orcid.org/0000-0002-8865-3764
2Stefan LLiana
3Morgovan CMClaudia Mona
4Duteanu NNarcishttps://orcid.org/0000-0002-5015-9306
5Dejeu ILIoana Laviniahttps://orcid.org/0000-0002-4435-1502
6Marian EEleonorahttps://orcid.org/0000-0002-6181-1590
7Vicaș LLaurahttps://orcid.org/0000-0001-5328-333X
8Manole FFelicia

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
QuercetinMajor topic
Biological AvailabilityMajor topic
AntioxidantsMajor topic
Anti-Inflammatory AgentsMajor topic
Humans
Animals
Flavonols
Secondary Metabolism

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References326

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,938,614Quercetin improves the imbalance of Th1/Th2 cells and Treg/Th17 cells to attenuate allergic rhinitis.Autoimmunity2023https://conductscience.org/library/papers/36938614PubMed
226,573,879Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.Mol Nutr Food Res2016https://conductscience.org/library/papers/26573879PubMed
325,728,636Anti-inflammatory activity and molecular mechanism of delphinidin 3-sambubioside, a Hibiscus anthocyanin.Biofactors2015https://conductscience.org/library/papers/25728636PubMed
432,566,174Review of the effects of vitexin in oxidative stress-related diseases.Food Sci Nutr2020https://conductscience.org/library/papers/32566174PubMed
532,443,914Antiviral Activities of Quercetin and Isoquercitrin Against Human Herpesviruses.Molecules2020https://conductscience.org/library/papers/32443914PubMed
621,964,380Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells.Neurosci Lett2011https://conductscience.org/library/papers/21964380PubMed
723,194,187Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells.Biochem Cell Biol2012https://conductscience.org/library/papers/23194187PubMed
835,160,478Preparation and Characterization of Chitosan-Alginate Microspheres Loaded with Quercetin.Polymers (Basel)2022https://conductscience.org/library/papers/35160478PubMed
937,446,644A Review of Classification, Biosynthesis, Biological Activities and Potential Applications of Flavonoids.Molecules2023https://conductscience.org/library/papers/37446644PubMed
1036,558,166Extraction of Naringin from Pomelo and Its Therapeutic Potentials against Hyperlipidemia.Molecules2022https://conductscience.org/library/papers/36558166PubMed

1 to 10 of 326

See all 326 references

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
42,979,440Pharmacological agents for promoting diabetic wound healing.Acta Pharm Sin B2026https://conductscience.org/library/papers/42979440PubMed
42,941,215Quercetin Differentially Modulates MTT-Derived Cellular Metabolic Activity and Apoptosis-Related Gene Expression in A549 and BEAS-2B Cells.Metabolites2026https://conductscience.org/library/papers/42941215PubMed
42,898,042A Review on Cyanidin-3-O-glucoside Antioxidant Activity, Food Technology Applications and Therapeutic Uses.J Food Sci2026https://conductscience.org/library/papers/42898042PubMed
42,884,573Targeting of Oral Bacterial Taxa Linked to Disease by Flavonols.Nutrients2026https://conductscience.org/library/papers/42884573PubMed
42,883,996Dihydroquercetin Activates AMPK/SIRT1/PGC-1α Signaling to Attenuate Arsenic Trioxide-Induced Apoptosis and Ferroptosis in AC16 Cells and HUVECs.Int J Mol Sci2026https://conductscience.org/library/papers/42883996PubMed
42,883,540Age-Related Variation in Flavonoid Composition, Human Pancreatic Lipase Inhibition, and Preliminary Brine Shrimp Lethality of Rhododendron adamsii Leaves and Sagan Dali Tea.Foods2026https://conductscience.org/library/papers/42883540PubMed
42,737,589Colocasia esculenta Corm Extract Attenuates Ethanol-Induced Gastric Ulcer by Suppressing NF-κB Expression: An Integrated Network Pharmacology Approach and In Vivo Validation.Int J Mol Sci2026https://conductscience.org/library/papers/42737589PubMed
42,726,435Large-scale comparative virtual screening identifies novel molecular targets underlying the multi-target activity of quercetin in psoriasis.Inflammopharmacology2026https://conductscience.org/library/papers/42726435PubMed
42,653,995Quercetin as a Multifunctional Flavonol: Molecular Insights and Therapeutic Applications.Molecules2026https://conductscience.org/library/papers/42653995PubMed
42,589,401Whey Protein-Based Micro- and Nanocapsules Loaded with Quercetin: Design and Functional Properties.Int J Mol Sci2026https://conductscience.org/library/papers/42589401PubMed

1 to 10 of 59

See all 59 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39596162

GET https://conductscience.org/api/papers/v1/39596162/references?page=2

API referenceFor AI assistants